Xiujuan Qu

机构：First Hospital of China Medical University, China Medical University · ORCID：0009-0005-9366-2314

发表论文 398 篇 · 总被引 8706 次 · h-index 47

代表论文

• Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial (2025 · The Lancet · 被引 128)
• CLDN18.2–targeting antibody–drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial (2025 · Nature Medicine · 被引 40)
• Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial (2025 · Gut · 被引 14)
• Targeting Intratumoral Bacteria for Cancer Treatment (2025 · Small · 被引 11)
• TROP-2-targeted antibody-drug conjugate SHR-A1921 for advanced or metastatic solid tumors: A first-in-human phase 1 study (2025 · Cancer Cell · 被引 10)
• Safety and efficacy of TQB2102, a novel bispecific anti-HER2 antibody–drug conjugate, in patients with advanced solid tumors: Preliminary data from the first-in-human phase 1 trial. (2025 · Journal of Clinical Oncology · 被引 7)